University of California Los Angeles
University of California Los Angeles
Los Angeles, California, United States10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 3 | 2026-10-07 | NCT06246916 | |
| Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) | Central Line Associated Blood Stream Infections (CLABSI) | Recruiting | Phase 3 | 2026-09-25 | NCT06822426 | |
| Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans | Stress Disorders, Traumatic, acute stress disorder, generalized anxiety disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Not applicable | 2026-08-31 | NCT05120635 | |
| A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | Disease Attributes, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-08-21 | NCT06769698 | |
| Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment | Cognition Disorders, Cognitive Dysfunction, cognitive disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-08-10 | NCT04558164 | |
| Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2026-07-13 | NCT06427954 | |
| A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 / Phase 2 | 2026-06-25 | NCT04219254 | |
| A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma | Disease Attributes, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 3 | 2026-04-09 | NCT06064877 | |
| Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Enrolling by invitation | Phase 2 | 2025-12-10 | NCT06126380 | |
| Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer | Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, skin squamous cell carcinoma, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Phase 2 | 2025-01-27 | NCT04050436 |